Exact Sciences Corporation EXAS NASDAQ

Exact Sciences Corporation (EXAS) reported total assets of $5.86B and total liabilities of $3.46B for quarter ending 2025-12-31, resulting in total equity of $2.4B.

The company held $964.71M in cash and short-term investments. Total debt stood at $2.52B, with net debt of $1.57B. The Debt-to-Equity (D/E) ratio was 1.05 (moderate).

Current ratio is 2.23, indicating strong short-term liquidity. Interest coverage is -9.3x (weak).

Criteria supported by this page:

• HEALTH (50/100, Partial) — some metrics are adequate but not all reach ideal thresholds
• MOAT (71/100) — Total assets $5.86B and equity $2.4B support the company's competitive scale
• VALUE (35/100) — Debt-to-Equity 1.05 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 36/100 with 1/7 criteria passed.